Liu 2021 / ChiCTR1900028351

Study ID(s) and Acronym(s)
ChiCTR1900028351
Current Status of Trial
Protocol/Planned
Study Aim
Treatment MCI
Study Design
RCT
Blinding
Single-blind
Intervention type
Non-pharmacological
Intervention
Health Education
Dosage and Duration
This study is a single-blinded, randomized, prospective clinical trial. We will recruit 132 participants with MCI who will be randomly assigned to a TTM-based health education group and a standard health education group in a ratio of 1:1. The intervention group will receive a TTM-based health education program (1 session/week, 4-560 min/session for 8 weeks), while the control group will receive standard health education. Assessors blinded to participant allocation will conduct baseline, post-intervention, and 3-month follow-up assessments.
Absolute Number of Participants
132
Health Status/Diagnosis
Mild Cognitive Impairment (MCI)
Primary outcomes
Cognition